Adjuvant hepatic intra-arterial iodine 131- lipiodol following curative resection of hepatocellular carcinoma: a prospective randomized trial. World J Surg 2013; 37: 1356-1361.

Published: 30th July 2013

Authors: Chung AY, Ooi LL, Machin D, Tan SB, Goh BK, Wong JS et al. et al.

Conclusion

Lipiodol was given 4-6 weeks after curative resection in this study of 103 patients. Recurrence-free survival (hazard ratio 0.75, 95 per cent confidence interval 0.46 to 1.23) and overall survival (0.88, 0.51 to 1.51) were not improved significantly.

Pubmed Link

Your comments

0 Comments